glp-1 off label use Japan Faces Shortage As Off-Label Diet Surges Trends in Glucagon-Like Peptide-1 Receptor

On the SoundLightUp test bench, a 3-in-1 fixture: a strobe, a wide and uniform RGB source and a moving light.

Conclusions/interpretation Our findings do not support an increased risk of SIS when taking GLP-1RA in individuals with type 2 diabetes and obesity

Managing weight loss while living with ulcerative colitis requires careful medication selection

Learn About the Safety and Effectiveness of Semaglutide GLP-1 for Weight Loss and How It Supports Sustainable Weight Management.

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.